LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1HRV Global Life Sciences
03 1Acura Labs
04 1Arene Lifesciences
05 1Aspire Lifesciences Pvt Ltd
06 1Aurobindo Pharma Limited
07 1Beijing Mesochem Technology
08 1Chromo Laboratories
09 1Divis Laboratories
10 1Emcure Pharmaceuticals
11 2Hetero Drugs
12 1Laurus Labs
13 1Lee Pharma
14 2Lupin Ltd
15 1Maithri Drugs
16 1Prajna Generics
17 1SGMR Pharmaceuticals
18 1SMS Pharmaceuticals
19 1Saintsun Pharma
20 1Shenzhen Oriental Pharmaceutical
21 1Teva Pharmaceutical Industries
22 1Tianish Laboratories
23 2Viatris
24 1Viwit Pharmaceuticals Limited
01 4China
02 19India
03 1Israel
04 3U.S.A
01 7Active
02 2Inactive
03 18Blank
01 1Valid
02 26Blank
01 27Blank
01 1WC-0030
02 1WC-0040
03 1WC-0213
04 1WC-0436
05 1WC0436
06 22Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36083
Submission : 2021-06-30
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-31
Pay. Date : 2013-12-09
DMF Number : 27728
Submission : 2013-12-24
Status : Active
Type : II
NDC Package Code : 65015-841
Start Marketing Date : 2015-01-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-09-02
Pay. Date : 2016-06-21
DMF Number : 30595
Submission : 2016-06-24
Status : Active
Type : II
NDC Package Code : 65015-841
Start Marketing Date : 2015-01-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26935
Submission : 2013-03-28
Status : Inactive
Type : II
Date of Issue : 2023-07-03
Valid Till : 2025-07-02
Written Confirmation Number : WC-0213
Address of the Firm :
Date of Issue : 2019-06-17
Valid Till : 2022-06-16
Written Confirmation Number : WC-0030
Address of the Firm :
NDC Package Code : 62331-055
Start Marketing Date : 2008-05-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Korea MSD Co., Ltd.
Registration Date : 2017-05-18
Registration Number : Su90-20-ND
Manufacturer Name : Divi\'s Laboratories Limited@(Undifferentiated Process) MSD International GmbH(Singapore Branch)
Manufacturer Address : Unit-2, Chippada(V) Annavaram(Post), Bheemunipatnam(M) Visakhapatnam District-531 162 Andhra Pradesh, India@50 Tuas West Drive Singapore 638408
We have 24 companies offering Raltegravir Potassium Salt
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?